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Background: In children, the prevalence’s of both obesity and asthma are disconcertingly high. Asthmatic children
with obesity are characterised by less asthma control and a high need for asthma medication. As the obese
asthmatic child is becoming more common in the clinical setting and the disease burden of the asthma-obesity
phenotype is high, there is an increasing need for effective treatment in these children. In adults, weight reduction
resulted in improved lung function, better asthma control and less need for asthma medication. In children this is
hardly studied. The Mikado study aims to evaluate the effectiveness of a long term multifactorial weight reduction
intervention, on asthma characteristics in children with asthma and a high body weight.
Methods/design: The Mikado study is a two-armed, randomised controlled trial. In total, 104 participants will be
recruited via online questionnaires, pulmonary paediatricians, the youth department of the Municipal Health
Services and cohorts of existing studies. All participants will be aged 6–16 years, will have current asthma, a Body
Mass Index in the overweight or obesity range, and no serious comorbidities (such as diabetes, heart diseases).
Participants in the intervention arm will receive a multifactorial intervention of 18 months consisting of sessions
concerning sports, parental involvement, individual counselling and lifestyle advices including dietary advices and
cognitive behavioural therapy. The control group will receive usual care. The primary outcome variables will include
Forced Expiratory Volume in one second and Body Mass Index - Standard Deviation Score. Secondary outcomes will
include other lung function parameters (including dynamic and static lung function parameters), asthma control,
asthma-specific quality of life, use of asthma medication and markers of systemic inflammation and airway inflammation.
Discussion: In this randomised controlled trial we will study the potential of a multifactorial weight reduction
intervention to improve asthma-related outcome measures in asthmatic children with overweight. Moreover, it will
provide information about the underlying mechanisms in the relationship between asthma and a high body weight in
children. These findings can contribute to optimal management programs and better clinical guidelines for children
with asthma and overweight.
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The increase in childhood obesity in recent decades is a
worldwide problem. The global prevalence of overweight
and obesity in children increased from 4.2% in 1990 to
6.7% in 2010 [1]. Similar to childhood obesity, the preva-
lence of childhood asthma has been rising in the previ-
ous decades [2]. Asthma is a common chronic disease in
children, and accounts for many disability-adjusted life
years and considerable medical costs [3].
Several studies demonstrated an association between
obesity and childhood asthma [4,5]. A recent meta-analysis
by Chen et al. showed a dose-responsiveness of elevated
BMI on asthma incidence, expressed as a relative risk (RR)
of 1.19 (95%CI: 1.03-1.37) for overweight and a RR of 2.02
(95%CI: 1.16-3.50) for obesity to develop future asthma
[5]. Furthermore, obesity is associated with less asthma
control and more use of oral corticosteroids [6,7].
Various potential pathophysiological theories have been
proposed to explain the association between obesity and
asthma. The first theory supports the mechanical effect of
obesity on asthma, as obesity can adversely impact lung
volumes. It is associated with reductions in Vital Capacity
(VC), Forced Expiratory Volume in 1 second (FEV1) and
Expiratory Reserve Volume (ERV) [8,9]. Reduced lung
volumes in obesity may result in reduced peripheral airway
diameter, which subsequently may disturb smooth muscle
function and potentially increase airway obstruction and
Bronchial Hyper-Responsiveness (BHR) [8]. A second
theory that has received growing attention is the effect
of obesity on asthma via inflammatory pathways [7,10].
The chronic inflammatory process created by excess adi-
posity has been implicated as being an underlying factor
in asthma pathogenesis. An increase in fat mass is associ-
ated with an increase in systemic inflammatory mediators
which can exacerbate airway inflammation via inflamma-
tory mediators such as leptin, adiponectin, Interleukin-6
(IL-6) and Tumour Necrosis Factor-alpha (TNF-α) [7,10].
Several studies noted that the pro-inflammatory effects of
serum leptin can modulate airway inflammation [7,11,12].
In addition to those theories, multiple factors are studied
which possibly play a role in the asthma-obesity relation-
ship such as dietary factors, a sedentary lifestyle, genetic
predisposition, metabolic abnormalities and associated
comorbidities such as gastro-oesophageal reflux disease
and sleep apnoea [4]. It is most likely that these influen-
tial factors and theories are not mutually exclusive, but
altogether explain the relationship between asthma and
obesity [12].
As obesity has a major impact on several asthma param-
eters, the effect of weight reduction in obese asthmatic
children could be of great value for current treatment
guidelines. Studies in adults concerning weight loss and
its effect on asthma are promising [13-15]. Significant
improvements have been found on asthma control, lungfunction, exacerbations and use of asthma medication
after weight loss [14]. In children, the effects of weight
loss have been hardly studied. As the obese asthmatic
child is becoming more common in the clinical setting,
there is need for a well-designed randomised controlled
trial (RCT) in which the effects of weight reduction on
asthma in children are studied.
Objective and hypothesis
The Mikado study is an RCT in which the effects of an
18-month multifactorial intervention, on several asthma
parameters and anthropometric outcomes in children with
asthma and overweight are studied. We hypothesise that
a multifactorial intervention will decrease the Body Mass
Index –Standard Deviation Score (BMI-SDS) of children
with asthma and overweight and will improve asthma re-
lated parameters including lung function, airway inflam-
mation, asthma control and the use of asthma medication.
The primary research question is
What are the effects of an 18-month multifactorial inter-
vention on FEV1%predicted and BMI-SDS?
The secondary research questions are
– What is the effect of a multifactorial intervention on
the severity and control of asthma as indicated by
lung function (FEV1/FVC, ERV), asthma symptoms,
asthma control, asthma-related quality of life,
Exercise Induced Bronchoconstriction (EIB), use of
asthma medication and exacerbations?
– What are the underlying mechanisms? Is the
intervention accompanied by decreased levels of
adipokines and diminished airway inflammation?
Can we detect a beneficial effect on airway
mechanics/lung function?
– What are the potential moderators and mediators of
the intervention effects (e.g. anthropometric
changes, changes in physical activity and dietary




The study design is an RCT for children with overweight
and asthma (Figure 1). Children aged 6–16 years living
in Southern Limburg, the Netherlands will be recruited.
After a screening visit, participants will be randomised
into an intervention group or a control group (Figure 1).
The intervention group will receive an intervention last-
ing for 18 months (see details below), while the control
group will receive standard usual care according to the
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- 9 lifestyle sessions
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week
- 3 individual 
counselling sessions
- 4 parental sessions
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Figure 1 Flow diagram study design. Abbreviations: BHR = Bronchial Hyper-Responsiveness, BMI = Body Mass index, EBC = Exhaled Breath
Condensate, FeNO = Fractional exhaled Nitric Oxide, VO2max = Maximal Oxygen Uptake.
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Society of Paediatrics [16,17].
Regular measurements including lung function out-
comes, anthropometric outcomes, inflammatory out-
comes and intervention mediators and moderators will
be performed at baseline (T=0), after 6 months (T=6),
12 months (T=12) and at the end of the intervention
(T=18). Every 3 months, participants will receive vari-
ous questionnaires (Table 1). All procedures and mate-
rials are approved by the Medical Ethic Committee of
Maastricht (MEC 09-2-088).
Recruitment
Children will be recruited from 4 sources. The first source
is a community-based random online questionnaire to
parents of 40,000 children in Southern Limburg. The
second source includes pulmonary paediatricians of 3 local
hospitals. Thirdly, children are recruited via the youth
section of the Municipal Health Services in Southern
Limburg. Additionally, children are recruited via cohorts
of several other studies [18,19].
All parents will be asked to fulfil an online question-
naire about anthropometric values and asthma symptoms.Children who are overweight according to the parental
reported BMI and who reported current asthmatic
symptoms and/or use of asthma medication will be in-
vited for a screening visit. Written informed consent
will be obtained from all parents and from children aged
12 years or older.
Eligibility criteria
All children with asthma and overweight, aged 6–16 year,
living in Southern Limburg will be invited to participate.
Overweight will be defined as a BMI-SDS >1 according
to the Lambda Mu and Sigma (LMS) method of Cole et al.
[20] based on the reference charts of the Dutch fourth
Nationwide Growth Study [21]. During the screening
visit, participants will undergo lung function measure-
ments to verify the diagnosis of asthma. A child will be
considered asthmatic if at least 2 of the 3 following cri-
teria are fulfilled: 1. asthmatic symptoms in the previous
12 months based on the International Study of Asthma
and Allergy in childhood (ISAAC) questionnaire [22];
2. use of Short Acting Beta2agonists (SABA), Long Acting
Beta2agonists (LABA) or Inhaled Corticosteroids (ICS)
in the previous 6 months; 3. reversibility; defined as an
Table 1 Overview of measurements per visit
Baseline T3 T6 T9 T12 T15 T18
Lung function parameters
MEFV curves: FEV1, FVC, FEV1/FVC, PEF, MEF50 (absolute and %predicted values)
* X X X X
Static lung function test: TLC, RV, FRC, ERV X X
BHR X
Maximum Ergometry test: VO2max, HRmax, %fall in FEV1 X X
Inflammatory parameters
FeNO X X
EBC: pH, IL-1α, 2, -4, -5, -10, -13, TNF-α, sICAM-1 X X
Serum: leptin X X
Questionnaires
PAQLQ verbal questionnaire for 6–11 year, written questionnaire for 12–16 year X X X X
EQ-5D-Youth questionnaire X X X X X X X
c-ACT questionnaire for 6–11 year, ACT questionnaire for 12–16 year X X X X
ISAAC questionnaire + additional questions about symptoms and exacerbations. Parental version for 6–
11 year, self-administered version for 12–16 year
X X X X
GERD questionnaire. Parental version for 6–11 year, self-administered version for 12–16 year X X X X X X X
PSQ questionnaire. Parental version for 6–11 year, self-administered version for 12–16 year X X X X
c-DEBQ questionnaire version for 6–11 year, DEBQ for 12–16 year X X
SDQ questionnaire. Parental version for 6–11 year, parental and self-administered version for 12–16 year X
Demographic factors: e.g. smoking, pets, parental educational level and BMI X X
Medication use X X X X X X X
Health care utilization X X X X X X X
Anthropometric values
Weight X Xi X Xi X Xi X
Length X Xi X Xi X Xi X
Waist and hip circumference X X X X
4-fold Skinfold measurement X X X X
Intervention outcome measures
3 × 24 hour food record X Xi X X X
7 days accelerometer output X Xi X X X
Continuously measured parameters
Percentage presence during the sport sessions, lifestyle sessions, parental sessions and individual counselling sessions. Average heart beat during the
sport sessions, BORG score of fatigue [59] after the sport sessions, motivation of the participants (1–10) rated by the sport instructor after the sport
sessions, amount of asthma attacks during sporting and safety of the participants.
Legend: * Pre- and post-bronchodilator spirometry will be obtained during every visit to determine reversibility. At baseline, reversibility will be determined after
the BHR test. Xi = Data only obtained in the intervention group.
Abbreviations: ACT, Asthma control test; BHR, Bronchial hyper-responsiveness; BMI, Body mass index; BORG, Perceived exertion and pain scale; c-ACT, Childhood
asthma control test; c-DEBQ, Childhood dutch eating behavioural questionnaire; DEBQ, Dutch eating behavioural questionnaire; ERV, Expiratory reserve volume;
EQ-5D-Youth, Youth version of Euroqol 5D quality of life questionnaire; FEV1, Forced expiratory volume in 1 second; FRC, Functional residual capacity; FVC, Forced
vital capacity; GERD, Gastro oesophageal reflux disease; HRmax, Maximum heart rate; IL, Interleukin; ISAAC, International study of asthma and allergy in childhood;
MEF50, Maximum expiratory flow rate at 50% of vital capacity; PAQLQ, Paediatric asthma quality of life questionnaire; PEF, Peak expiratory flow, pH, Acidity; PSQ,
Paediatric sleep questionnaire; RV, Residual volume; SDQ, Strengths and difficulties questionnaire; sICAM-1, Soluble intercellular adhesion molecule-1; TLC, Total
lung capacity; TNF-α, Tumour necrosis factor-alpha; VO2max, Maximal oxygen uptake.
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inhalation of 400 μg Airomir (Teva Pharma, Leiden,
the Netherlands) or a positive BHR test; defined as a
histamine concentration of ≤8 mg/ml necessary to pro-
voke a drop of 20% in FEV1.Children will be excluded in the case of a congenital mal-
formation of the airways or other chronic lung diseases,
syndromes accompanied by mental retardation or meta-
bolic diseases, physical limitations to exercise, and/or a
heart disease.
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All children who meet the inclusion criteria after the
screening visit will be randomised to either the control
or intervention group. Generalised block randomisation
including 10 participants per block will be performed by a
computer program, with an allocation ratio of 1:1 [23]. Be-
cause this is a lifestyle study, blinding is not possible.
Outcome measures
An overview of all the outcome measurements and cor-
responding time points can be found in Table 1.
Lung function measurements
Maximal Expiratory Flow Volume (MEFV) curves will
be measured with a spirometer (ZAN Messgerate,
Oberthulba, Germany) according to American Thoracic
Society / European Respiratory Society (ATS/ERS) guide-
lines [24]. LABA will be withheld 48 hours and SABA
8 hours before the measurement. During these mea-
surements all children will be instructed by experienced
researchers and nurses specialised in lung function
measurements. The highest value of 3 technically ap-
propriate measurements will be recorded and predictive
values will be calculated according to prediction formulas
of Zapletal et al. [25]. Reversibility will be defined as a
change of ≥9% in FEV1 after 400 μg of extra-fine salbu-
tamol (Airomir, Teva Pharma, Leiden, the Netherlands).
During T0 reversibility will be determined after the com-
pletion of the BHR test.
Static lung function indices will be determined by body
plethysmography (Viasys, Hoechberg, Germany) according
to the ATS/ERS guidelines [24]. BHR will be determined
by a histamine provocation test. A dose of histamine will
be increasingly administered until a drop of 20% of the
FEV1 is obtained or until a dose of 16 mg/ml histamine is
reached [26]. The provocative concentration that will lead
to a drop of 20% of the FEV1 (PC20) will be determined
by linear interpolation of the last 2 points on the log
dose–response curve.
Anthropometric measurements
Children will be weighed while wearing underwear and
without shoes. Length will be measured twice to the
nearest 0.5 centimetre (Stadiometer model 213, Seca,
Birmingham, United Kingdom). Weight will be measured
twice to the nearest 0.1 kilograms using a medical cali-
brated weight scale (Model 877, Seca, Hamburg, Germany).
The average weight and height measurement will be
used to calculate the BMI. BMI-SDS scores will be de-
fined by the LMS-method of Cole et. al [20] based on
the reference charts of the Dutch fourth Nationwide
Growth Study [21].
Skinfold thickness will be derived from the triceps, biceps,
subscapular and supra iliacic skinfolds by a Skinfold Calliper(Harpenden, British Indicators, Sussex, United Kingdom).
Fat percentages will be generated by using the formulas of
Deurenberg et al. [27]. Waist-hip ratio will be obtained by
measuring the hip and waist circumference for each visit.
Both skin fold thickness and waist-hip circumference
measurements will be performed twice according to inter-
national guidelines [28].Maximal ergometry test
All patients will perform a maximal incremental ergometer
test (Reha Ergometer, Ergoline, Bitz, Germany) by using a
continuous ramp protocol [29]. LABA will be withheld
48 hours and SABA 8 hours before the maximal ergometry
test. During the test, breath by breath gas exchange will be
analysed by a mass spectrometer (Oxicon Pro, Carefusion,
Hochberg, Germany), and Heart Rate (HR) by means of a
continuous 12-lead electrocardiogram (Masterscreen ECG,
Carefusion, Hochberg, Germany).
The pedalling frequency will be held at 60 rpm and
participants will be encouraged during the test to con-
tinue as long as possible. At the start, children will rest
for 3 minutes in seated position followed by 3 minutes
of cycling at the first increment, which is determined by
length. Children below 120 cm will undergo a protocol
with 10 W/min increment, children 120–150 cm will
undergo a protocol with 15 W/min and a 20 W/min
increment will be used in children >150 cm.
During the test, the wattage will incrementally increase
until children can no longer continue the pedalling fre-
quency for at least 5 seconds, or if termination is required
according to other standard safety criteria. After exhaus-
tion, children will continue to cycle for 3 more minutes at
the first increment. The test will be accepted if at least 2
of the following criteria will be reached: 1. <2 ml/kg/min
increase in oxygen uptake (VO2) with increasing work load,
2. Respiratory Exchange Ratio > 1.00, 3. HR ≥85%pre-
dicted (as assessed by 220 minus age). During the test
the following variables will be measured: HR, Minute
ventilation (V’E) and VO2 in L/min and in L/min/kg
bodyweight. The Anaerobic Threshold will be determined
by the V-slope method as described by Beaver et al. [30],
predicted values will be calculated according to normal
values of Ten Harkel et al. [31].
MEFV curves will be determined by a spirometer (ZAN
Messgerate, Oberthulba, Germany) before exercise, 10 and
30 minutes after completion of the maximal exercise test.
The severity of EIB will be measured as the difference in
pre-exercise and post-exercise FEV1.Questionnaires
Information on socio-demographic characteristics such
as age, sex, ethnicity, parental BMI, social economic
status and smoking exposure will be collected. Asthma
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(ACT) in children >11 years [32]. The childhood ACT
(C-ACT) will be used in children ≤11 years [32,33]. A
score of ≤19 will be defined as uncontrolled asthma [34].
Medication use will be evaluated over the 2 months period
prior to the clinic visit and dose equivalents will be calcu-
lated according to standard dosage of SABA, LABA and
ICS [16,17,35,36]. The GINA guidelines will be used to
determine asthma severity (intermittent, mild, moderate
and severe) based on the intensity of treatment [37]. A
Dutch questionnaire and the ISAAC questionnaire will be
used to measure asthma symptoms [38]. Asthma-related
quality of life will be measured by the Paediatric Asthma
Quality of Life Questionnaire (PAQLQ) [39]. According to
the PAQLQ guidelines, the minimal important difference
will be defined as a difference of 0.42 points [40]. The
Euroqol 5D Youth version will be used as a measurement
tool for general health related quality of life [41].
To investigate commonly associated morbidity in chil-
dren with asthma, sleep related breathing disorders will be
assessed by means of the Paediatric Sleep Questionnaire
(PSQ) [42]. A score of >0.33 will be defined as having a
high risk for developing a sleep-related breathing disorder
[42]. The existence of Gastro-Oesophageal Reflux Disease
(GERD) symptoms will be assessed by the GERD ques-
tionnaire [43]. A suspicion of GERD is present when the
score is ≥ 3 points [43]. Psychosocial problems will be
determined by an abnormal score on the Dutch version
of the Strength and Difficulties Questionnaire (SDQ)
according to the SDQ scoring guidelines [44]. In addition,
the Dutch Eating Behaviour Questionnaire (DEBQ) will
be used to determine whether children have high scores
on the subscales: Emotional Eating (13 items), External
Eating (10 items) or Restrained Eating (10 items) [45].
Atopy, systemic and airway inflammation
Systemic inflammation will be determined in blood serum.
The serum concentration of leptin will be determined in
100 microliter of plasma by means of multiplex immuno-
assay (Luminex Corporation, Austin, TX, USA). Airway
inflammation will be measured by means of Fractional ex-
haled Nitric Oxide (FeNO) and markers in Exhaled Breath
Condensate (EBC). FeNO will be obtained with the online
NIOX analyser (Aerocrine, Solna, Sweden) according to
international guidelines [46]. EBC will be collected by
means of an optimised glass tube, cooled by counter-
current circulating ice water as described previously [18].
In short, children will breathe tidally into the cooled glass
tube for 10 minutes, while wearing a nose-clip, through a
mouthpiece connected to a 2-way non-rebreathing valve.
Subsequently, acidity will be measured and the EBC sam-
ples will be frozen by using dry ice and stored at −80°C.
Levels of various cytokine, chemokines, and soluble inter-
cellular adhesion molecule-1 (sICAM-1) will bemeasured in 100 microliter EBC with multiplex immuno-
assay (Luminex, Luminex Corporation, Austin, USA) [47].
Physical activity and dietary behaviour
Physical activity level will be measured as the average
step count per day measured over a week. All children
will be instructed to wear a triaxial accelerometer (Yamax
EX510 Power Walker, Yamax, Tokyo, Japan) for 7 con-
secutive days. While wearing the accelerometer, all chil-
dren will keep a diary about the time spent on swimming
and cycling.
Dietary intake will be measured by means of 3-day food
records. Parents and children will receive a standardised
instruction based on the multiple-pass method about
fulfilling dietary records at the start of the study [48].
An online program (Vodiweb, Vodisys Medical Software,
Groningen, The Netherlands) will be used to calculate
nutrition composition, based on Western and local food
tables and normalised portion sizes [49]. The purpose
of this tool is to measure intake of energy and macro-
nutrients (fat, carbohydrate, protein) as well as to differ-
entiate between healthy and unhealthy snacking during
the day. A trained researcher will check all food diaries for
completeness.
Intervention
We incorporated the most effective components of current
weight reduction programs for children in our intervention
[50-53]. Several reviews and meta-analyses concluded that
long-term (>1 year) multi-component lifestyle interventions
targeted at both children and caregivers are most efficient
[50-53]. The health counselling model is the theoretical
basis of our intervention [54]. The most important compo-
nents of this intervention are sport sessions, lifestyle ses-
sions including dietary advices and cognitive behavioural
therapy, parental sessions, and individualised counselling.
Children will be divided in small groups of 8 to 12 children.
Intervention group allocation will occur according to
place of residence and age (6–11 years and 12–15 years).
To secure that intervention professionals adhere to the
protocol, all intervention professionals will meet on a
regular basis with a study coordinator as supervisor. The
intervention is divided in an initial phase (months 0–6)
and a follow-up phase (months 7–18) (Figure 1).
Theoretical basis of intervention
The theoretical foundation of the intervention is derived
from the health counselling model [54]. Health counsel-
ling is a model in which 3 phases for lifestyle changes
are included: preparations, behaviour change and follow-
up. The initial (preparation and behaviour change) phase
will be imbedded during the first 6 months of the inter-
vention in which there are frequent contact moments; the
follow-up phase will be imbedded in the last 12 months
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theories such as the Stages of Change Model, Theory of
Planned Behaviour, Social Cognitive Theory and Relapse
Prevention Model are imbedded [55-58]. The preparation
phase consists of 3 steps: 1. awareness (e.g. unhealthy eat-
ing and sedentary behaviour leads to obesity, which leads
to health problems and stigmatising), 2. consideration of
the new behaviour (e.g. benefits and disadvantages of los-
ing weight) and 3. decision making (e.g. shared decision
making including detecting and removing barriers). Dur-
ing the behaviour change phase children will receive more
information about healthy behaviour and will be encour-
aged in each session to set a specific goal which they add
to their personal goal list (e.g.: ‘I will walk the dog at least
4 days a week for 30 minutes’). In the follow-up phase
children will learn how to preserve their behaviour (e.g.
creating reminders of their goal-lists in their home envir-
onment, avoiding risk situations, learning social and cop-
ing skills) and eventually relapse strategies will be made
(e.g. making a ‘first aid box for difficult situations’).Sport sessions
Sport sessions will consist of regular group exercises
(twice a week during initial phase, three times a month
during the follow-up phase, Figure 1), with a duration of
60 minutes per session. All sport sessions will be guided
by an experienced paediatric physiotherapist or a paedi-
atric sport instructor. A session will consist of 10 minutes
warming-up, 20 minutes aerobic exercises, 20–25 minutes
interval exercise games and 5 minutes cooling-down. In
order to offer an enjoyable program, several recreational
sports will be played such as basketball, soccer, rope
skipping, and tag games. The duration and intensity of
the exercises will gradually increase during the first
3 months of the exercise program. Intensity of the exer-
cise will be held at 60-75% of the age-adjusted maximal
HR. All participants will wear a heart rate monitor (polar
FS3c, Polar Electro Oy, Kempele, Finland,) during each
sport sessions. During and after the sport sessions the
(average) HR of each participant will be evaluated by the
sports instructor. In addition, Borg’s perceived exertion
scale is used to monitor exertion [59]. If advised by the
children’s physician, sport instructors will encourage par-
ticipants to use SABA 15 minutes before exercise.
During the initial phase participants will be motivated
by their sports instructor to choose a supervised sport
in their own environment, which children will practice
during the follow-up phase. All participants will be en-
couraged to visit at least 3 different sport clubs in the
vicinity of their residence. Folders with sport facilities in
the environment will be provided. All parents will be
encouraged to support their child to find a new sport
during the parental sessions.Lifestyle sessions
An experienced dietician and psychologist will guide 18
lifestyle sessions with a duration of 75–90 minutes. A
session will consist of weighing, evaluation of the previous
weeks, personalised goals and BMI-SDS curve, dietary
advice usually incorporated in a game, psychological
training, personalised goal setting and discussing home
work. All children will receive a workbook with add-
itional information for each lifestyle session, homework
and space for individualised goal setting. All children
will set at least one new personalised goal per session
during the initial phase. In the follow-up phase, children
will be encouraged to maintain their goals and modify
goals in case of no BMI-SDS reduction. Small presents
will be provided as incentives for participation and
achievements. Individualised incentives will be obtained
if personalised goals are reached and group incentives
will be obtained in case of high participation rates and
preparations for the lifestyle sessions. The dietician and
psychologist will put emphasis on positive reinforcement
during the lifestyle sessions.
All dietary advices are based on the Dutch dietary
guidelines for children with a high body weight [60] and
modelled after the work of Dutch programs to prevent
childhood obesity, Realfit and Slimkids [61]. During the
sessions, children will follow 3 basic dietary guidelines:
1. healthy food choice, 2. regular eating pattern, and 3.
normalised portion sizes. Other dietary themes that will
be dealt with during the lifestyle sessions are among others:
energy balance, fruit and vegetable intake, mindful eating,
finding social support, trying new food items (including
2 taste session sessions) inspecting food labels and, if
applicable, alcoholic beverages. Special attention will be
paid to emotional eating, body dissatisfaction and disor-
dered eating. Also, children will regularly comment on
their own and other’s dietary journals. If children have
not reduced their BMI-SDS after 6 lifestyle sessions, the
dietician will provide the children with a personalised
balanced hypo caloric diet with low-fat, nutrient dense
foods of moderate proportion sizes. The diet will consist
of a caloric restriction of 15% less than required [62].
Participants and parents will be guided and encouraged
by the dietician to follow the hypo caloric diet and to
adjust the diet with the nutritional knowledge they have
gained during the previous sessions.
The psychologist will teach cognitive behavioural tech-
niques. Children will learn how to identify, challenge and
change dysfunctional cognitions about weight/obesity, food/
eating, bullying, self-esteem, sedentary behaviour and
physical activity by means of background information
and homework assignments including ‘thought diaries’.
Other themes on which the psychologist will focus are
motivation monitoring, stimulus control, recognizing
emotions and social skills. Children will be taught how
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celebrations, and restaurants. During the follow-up phase
a relapse prevention schedule will be made by all partici-
pants. The cognitive behaviour protocols were modelled
after the work of Werrij et al. [63,64].
The dietician and psychologist will guide participants
to decrease sedentary behaviour. Children will be moti-
vated to reach the advised daily 60 minutes of moderate
to vigorous physical activity and to perform exhaustive
physical activity for 20 minutes at least 3 days per week.
Main themes to be discussed are screen time, active
transportation ways and daily activity patterns.
Parental sessions
Parents will follow 10 parental sessions of 60 minutes
guided by the dietician and psychologist who also guide
the lifestyle sessions. A parental session will consist of
an evaluation of the prior period, summarising the content
of children’s lifestyle sessions, dietary or psychological in-
formation and goal setting. The parents will receive a
workbook including background information, healthy rec-
ipes and sport facilities in their residence. The dietary infor-
mation will consist of standard nutritional education that is
also taught to the children. In addition, advices are given
about healthy cooking habits, preparing healthy snacks for
children and visibility of (un)healthy food at home. The
psychologist will focus on parental techniques such as posi-
tive rewarding, managing problem behaviours and model-
ling behaviour of the parents. Emphasis will be put on the
importance of individual incentives if children reach their
personalised learning goals.
Individual counselling sessions
In addition to the lifestyle sessions, children will receive
individualised counselling sessions. The individualised coun-
selling sessions will be guided by either the dietician or the
psychologist, dependent on the needs of the child. The
individualised counselling sessions will focus on the learn-
ing goals, motivational problems, personal barriers for
maintaining the leaning goals and possible depressive
symptoms. Children aged 6–11 years always attend the
individual sessions accompanied by a parent. Older chil-
dren will be accompanied by a parent if one of the parties
(e.g. dietician, psychologist, child or parents) deems a par-
ental visit beneficial. If the child still experiences severe
problems with weight reduction despite the regular life-
style sessions and individual consults, the dietician or
psychologist will schedule extra telephonic consults with
the child and/or parent.
Statistics
Sample size calculation
Earlier studies on weight loss in asthmatic adults dem-
onstrated improvements in FEV1 of 8% and 6%respectively [65,66]. In adolescents with asthma, im-
provements in FEV1 of up to 24% were found after a
weight reduction program [67]. In total, 104 participants
are sufficient to detect a change of 5% in FEV1%, assum-
ing a five-repeated measurement design of Hedeker
et al., a two-sided alpha of 5%, a correlation between
measurements of 0.7, a power of 80%, a sample size ratio
of 1:1, a drop-out rate of 5% and an autoregressive(1)
variance-covariance matrix structure [68].
According to the Fleisch method of power calculation,
80 participants are sufficient to detect a clinical relevant
decrease of 0.25 BMI-SDS, with a two-sided alpha of 0.05,
a drop-out rate of 20% and a power of 90% [69].
Data analysis of primary and secondary research question
Data will be analysed by using Statistical Package for the
Social Sciences (version 20.0, SPSS, Chicago, USA). Stand-
ard statistical techniques will be used for the baseline char-
acteristics. Normal distributed variables will be expressed
as means and standard deviations, non-normal distrib-
uted data will be presented as median with interquartile
ranges. Multi-level analyses techniques will be used to
test whether within-subject changes in FEV1%predicted
after 18 months intervention differ between intervention
and control group. Both per-protocol and intention-to-
treat-analyses will be performed. The primary outcome
FEV1%predicted will be tested two-tailed with an alpha
of 5%. Correction for multiple testing will be conducted
for the secondary outcomes.
Discussion
This paper describes the design of the Mikado study,
an RCT testing the effects of a multifactorial weight loss
intervention on asthma parameters in children with
overweight and asthma. The multifactorial intervention
consists of sessions concerning diet and behaviour, sport,
parental involvement and individual counselling. Emphasis
is put on individual goal setting, positive reflections and
reinforcements. The efficacy of the Mikado study will be
measured by regular anthropometric and lung function
measurements. In addition, this study should provide
enhanced understanding of the underlying pathophysi-
ology of the asthma-obesity relation in children.
The Mikado study is, up to now, the first RCT to inves-
tigate the effects of a weight reduction intervention on
asthma parameters in children. Strengths of the Mikado
study include its long duration, its broad range of out-
come measures and the fact that the intervention is
comprised of successful components of previous studies.
There are several critical success factors that should be
mentioned. Previous lifestyle studies in children have fre-
quently reported recruitment problems and dropout rates
as high as 42% [51,70]. The main reasons for these were
parental attitudinal issues, such as denial that their child
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ibility in making room in the family’s schedule for the pro-
gram, prohibitive costs and an unwillingness to change the
home environment. We will try to minimise these barriers
for recruitment by training the researchers in telephonic
skills, and by inviting hesitant participants for a personal
informative meeting regarding the study. Offering an
individualised programme and closely monitoring the par-
ticipants by the intervention team should minimalize
dropout. In case of high dropout rates, we will perform
a responsive evaluation to investigate the reasons [71].
Asthma is a chronic disease characterised by regular
symptoms, a decreased quality of life, and medication use
throughout the entire lifespan. Asthma in childhood has
many non-modifiable risk factors such as a family history
of asthma, sex and atopy [72]. Obesity is one of the few
modifiable risk factors for asthma, which implies the
necessity to investigate whether or not weight reduction
has the potential to improve asthma-related characteris-
tics. If proven effective, a weight reduction program should
be incorporated into the guidelines for childhood asthma.
Weight reduction in asthmatic children might lead to
an improved asthma prognosis via an improved asthma-
related quality of life, asthma control, and lung function.
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